These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18112057)

  • 1. Curariform activity and chemical structure; syntheses in the 3-indolylmethylamine series.
    CRAIG LE; TARBELL DS
    J Am Chem Soc; 1949 Feb; 71(2):462-5. PubMed ID: 18112057
    [No Abstract]   [Full Text] [Related]  

  • 2. Curariform activity and chemical structure; syntheses in the piperidine series.
    CRAIG LE; TARBELL DS
    J Am Chem Soc; 1949 Feb; 71(2):465-7. PubMed ID: 18112058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on the indole series. XVI. On aryl-2-tryptamines and homologous amines].
    Julia M; Mélamed R; Gombert R
    Ann Inst Pasteur (Paris); 1965 Sep; 109(3):343-62. PubMed ID: 5825523
    [No Abstract]   [Full Text] [Related]  

  • 4. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
    Johnson MP; Loncharich RJ; Baez M; Nelson DL
    Mol Pharmacol; 1994 Feb; 45(2):277-86. PubMed ID: 8114677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R; Mannocchi G; Pantano F; Romolo FS
    Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of beta,beta-difluorotryptamines.
    Deng WP; Nam G; Fan J; Kirk KL
    J Org Chem; 2003 Apr; 68(7):2798-802. PubMed ID: 12662054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiospecific Synthesis of β-Substituted Tryptamines.
    Rubin HN; Van Hecke K; Mills JJ; Cockrell J; Morgan JB
    Org Lett; 2017 Sep; 19(18):4976-4979. PubMed ID: 28880094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR.
    Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF
    Analyst; 2005 Mar; 130(3):330-44. PubMed ID: 15724162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.
    Dinger J; Woods C; Brandt SD; Meyer MR; Maurer HH
    Toxicol Lett; 2016 Jan; 241():82-94. PubMed ID: 26599973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the position and type of the substituent in a series of indolylalkylamines on electron-donor properties and radioprotector activity].
    Izmozherov NA; Aĭnbinder NE; Filaretov AN; Izmozherova EL
    Radiobiologiia; 1976; 16(6):917-9. PubMed ID: 1027040
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between chemical structure and pharmacological activity in a series of 5-alkoxy substitution derivatives of tryptamine.
    Arutyunyan GS; Mashkovskii MD; Roshchina LF
    Fed Proc Transl Suppl; 1965; 24(6):1108-10. PubMed ID: 5215181
    [No Abstract]   [Full Text] [Related]  

  • 12. The chemistry of indoles. CIII. Simple syntheses of serotonin, N-methylserotonin, bufotenine, 5-methoxy-N-methyltryptamine, bufobutanoic acid, N-(indol-3-yl)methyl-5-methoxy-N-methyltryptamine, and lespedamine based on 1-hydroxyindole chemistry.
    Somei M; Yamada F; Kurauchi T; Nagahama Y; Hasegawa M; Yamada K; Teranishi S; Sato H; Kaneko C
    Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):87-96. PubMed ID: 11201232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE MELTING POINT AND STRUCTURE OF TRYPTAMINE.
    JACKSON AH; SMITH AE
    J Chem Soc; 1965 May; ():3498-500. PubMed ID: 14302100
    [No Abstract]   [Full Text] [Related]  

  • 16. N(1)-substituted ergolines and tryptamines show species differences for the agonist-labeled 5-HT2 receptor.
    Johnson MP; Audia JE; Nissen JS; Nelson DL
    Eur J Pharmacol; 1993 Aug; 239(1-3):111-8. PubMed ID: 8223886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [RELATION OF THE CHEMICAL STRUCTURE ON PHARMACOLOGICAL PROPERTIES OF A NUMBER OF 5-ALKOXY-SUBSTITUTED TRYPATAMINE DERIVATIVES].
    ARUTIUNIAN GS; MASHKOVSKII MD; ROSHCHINA LF
    Farmakol Toksikol; 1964; 27():681-6. PubMed ID: 14321290
    [No Abstract]   [Full Text] [Related]  

  • 18. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS.
    Brandt SD; Freeman S; Fleet IA; Alder JF
    Analyst; 2005 Sep; 130(9):1258-62. PubMed ID: 16096671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New synthetic technologies for the construction of heterocycles and tryptamines.
    Nicolaou KC; Krasovskiy A; Majumder U; Trépanier VE; Chen DY
    J Am Chem Soc; 2009 Mar; 131(10):3690-9. PubMed ID: 19243142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines.
    Brandt SD; Tearavarich R; Dempster N; Cozzi NV; Daley PF
    Drug Test Anal; 2012 Jan; 4(1):24-32. PubMed ID: 22287290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.